Skip to main content

Table 1 Drug susceptibility results of the MFC isolate

From: Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report

Substance MIC Interpretation
Moxifloxacin 0.25 mg / L S
Ciprofloxacin 0.5 mg / L S
Amikacin 4.0 mg / L S
Linezolid 32.0 mg / L R
Clarithromycin 16.0 mg / L R
Imipenem 8.0 mg / L I
Cefoxitin 128 mg / L R
Doxycycline 16.0 mg / L R
Minocyclin 8.0 mg / L R
Cotrimoxazol 8/152 mg / L R
Tigecyclin 0.5 mg / L No breakpoints available
Clofazimine 0.06 mg / L No breakpoints available
Bedaquiline 0.015 mg / L No breakpoints available
Delamanid >  0.5 mg  / L No breakpoints available